Literature DB >> 11002770

Immunohistochemical detection of steroid receptors in breast cancer: a working protocol. UK Receptor Group, UK NEQAS, The Scottish Breast Cancer Pathology Group, and The Receptor and Biomarker Study Group of the EORTC.

R Leake1, D Barnes, S Pinder, I Ellis, L Anderson, T Anderson, R Adamson, T Rhodes, K Miller, R Walker.   

Abstract

The biochemical assay for the oestrogen receptor has shown the clinical value of knowing the concentration of the receptor within tissue. The immunohistochemical assay is rapidly taking over from the biochemical assay. Therefore, it is vital to have an equivalent scoring system that will have the same predictive value. This paper reports both a practical protocol and a scoring system that should achieve this aim. This approach should be applicable to many more biomarkers detected by immunohistochemistry.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11002770      PMCID： PMC1762930          DOI： 10.1136/jcp.53.8.634

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


  51 in total

1.  Breast cancer prognostication in the 21st century and the Nottingham prognostic index.

Authors:  T J Anderson
Journal:  J Clin Pathol       Date:  2002-02       Impact factor: 3.411

2.  Tissue microarrays: a new approach for quality control in immunohistochemistry.

Authors:  J Packeisen; H Buerger; R Krech; W Boecker
Journal:  J Clin Pathol       Date:  2002-08       Impact factor: 3.411

3.  Quantitative DCE-MRI for prediction of pathological complete response following neoadjuvant treatment for locally advanced breast cancer: the impact of breast cancer subtypes on the diagnostic accuracy.

Authors:  Stylianos Drisis; Thierry Metens; Michael Ignatiadis; Konstantinos Stathopoulos; Shih-Li Chao; Marc Lemort
Journal:  Eur Radiol       Date:  2015-08-27       Impact factor: 5.315

4.  Simultaneous evaluation of maspin and CXCR4 in patients with breast cancer.

Authors:  Efthimia Tsoli; Petros K Tsantoulis; Alexandros Papalambros; Branko Perunovic; David England; David A Rawlands; Gary M Reynolds; Dimitrios Vlachodimitropoulos; Susan L Morgan; Chara A Spiliopoulou; Thanos Athanasiou; Vassilis G Gorgoulis
Journal:  J Clin Pathol       Date:  2006-06-02       Impact factor: 3.411

5.  Breast cancer hormone receptor assay results of core needle biopsy and modified radical mastectomy specimens from the same patients.

Authors:  Gemma B Uy; Adriano V Laudico; Jose M Carnate; Frederick G Lim; Arnold M Fernandez; Rona R Rivera; Cynthia A Mapua; Richard R Love
Journal:  Clin Breast Cancer       Date:  2010-04       Impact factor: 3.225

6.  Prolactinoma ErbB receptor expression and targeted therapy for aggressive tumors.

Authors:  Odelia Cooper; Adam Mamelak; Serguei Bannykh; John Carmichael; Vivien Bonert; Stephen Lim; Galen Cook-Wiens; Anat Ben-Shlomo
Journal:  Endocrine       Date:  2013-11-28       Impact factor: 3.633

7.  Operation with less adjuvant therapy for elderly breast cancer.

Authors:  Akimitsu Yamada; Kazutaka Narui; Sadatoshi Sugae; Daisuke Shimizu; Kazuaki Takabe; Yasushi Ichikawa; Takashi Ishikawa; Itaru Endo
Journal:  J Surg Res       Date:  2016-05-26       Impact factor: 2.192

8.  Improvement of the clinical applicability of the Genomic Grade Index through a qRT-PCR test performed on frozen and formalin-fixed paraffin-embedded tissues.

Authors:  Jérôme Toussaint; Anieta M Sieuwerts; Benjamin Haibe-Kains; Christine Desmedt; Ghizlane Rouas; Adrian L Harris; Denis Larsimont; Martine Piccart; John A Foekens; Virginie Durbecq; Christos Sotiriou
Journal:  BMC Genomics       Date:  2009-09-10       Impact factor: 3.969

9.  Molecular characteristics of screen-detected vs symptomatic breast cancers and their impact on survival.

Authors:  S J Dawson; S W Duffy; F M Blows; K E Driver; E Provenzano; J LeQuesne; D C Greenberg; P Pharoah; C Caldas; G C Wishart
Journal:  Br J Cancer       Date:  2009-09-22       Impact factor: 7.640

10.  Androgen-related expression of G-proteins in ovarian cancer.

Authors:  L A Sheach; E M Adeney; A Kucukmetin; S J Wilkinson; A D Fisher; A Elattar; C N Robson; R J Edmondson
Journal:  Br J Cancer       Date:  2009-07-21       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.